Tag: global health

Blog Posts (4)

August 18, 2014

The raging Ebola epidemic in West Africa—will the key lessons be learned?

by Arthur Caplan, Ph.D.

Ebola, according to the World Health Organization (WHO) is out of control in West Africa.  The disease, which is transmitted by contact with contaminated blood or body fluids, or by close contact with a dead body infected with the virus, has killed more than 1100 people in Guinea, Sierra Leone, Liberia, and Nigeria. …

August 8, 2014

Ebola Outbreak Highlights Questions about Experimental Drug Treatment

<p class="MsoNormal">Questions regarding the availability and utilization of experimental drugs for treatment of disease have moved to the forefront following the apparently successful use of an <a href="http://www.cnn.com/2014/08/04/health/experimental-ebola-serum/index.html?hpt=hp_t1">experimental treatment</a> used for two American health workers treating the Ebola outbreak in West Africa. </p> <p class="MsoNormal">The questions that have been raised include both who such drugs should be made available to and under what circumstances they should be made available. An additional consideration is what processes should be put into place to assure that these decisions are made properly to allow patients with valid cases to obtain access while protecting ill people from inappropriate risks and suffering. An additional question which I will not delve into here is who pays for them. Health insurance does not pay for experimental treatments so someone else must. First I should clarify exactly what I mean by an experimental drug. I am referring to drugs that have a scientific rationale for their use and some scientific basis for believing they might work. I do not include cockamamie ideas with no reasonable basis simply because somebody thinks they should be used. I have <a href="/BioethicsBlog/post.cfm/hubris-and-biomedical-research ">previously written</a> about physicians who chose to use unreasonable treatments.</p> <p class="MsoNormal"><strong style="color: #34405b; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 20px;">The Alden March Bioethics Institute offers a Master of Science in Bioethics, a Doctorate of Professional Studies in Bioethics, and Graduate Certificates in Clinical Ethics and Clinical Ethics Consultation. For more information on AMBI's online graduate programs, please visit our <a style="text-decoration: underline; color: #000099;" href="/Academic/bioethics/index.cfm">website</a>.</strong> </p>
March 19, 2014

The importance of assisted reproductive technologies for women in “developing” countries

<p>While assisted reproductive technologies (ART) are common in most “developed” countries (the global North), in the global South (“developing” countries), ART is generally not available for a variety of reasons, most of which center around money. These resource-poor countries typically lack both qualified health-care professionals and facilities necessary for ART. Although some countries do have ART centers, the cost of ART is prohibitive for all but the extremely wealthy. Indeed, infertility is usually seen as a treatable problem only for the upper class primarily because the poor cannot afford basic health care let alone expensive treatment like ART. The fact that the majority of people in the global South cannot afford basic health care, which is typically seen as the top priority in health-care allocation, is another reason why ART are not readily available in the global South. Most public and private health-care funding goes toward primary care and not treatments that are often seen as elective and cosmetic, like ART.</p> <p>Yet, infertility can be considered a health problem according to the World Health Organization's broad definition of health – “Health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.” Infertility in the global South can have severe and interrelated social, economic, and health-related consequences for women. This is still the case when the woman is physiologically fertile but her partner has male factor infertility; she is the one who is generally blamed for the couple’s inability to have a biological child.</p> <p><strong style="color: #34405b; font-family: Arial, Helvetica, sans-serif; font-size: 12px; line-height: 20px;">The Alden March Bioethics Institute offers a Master of Science in Bioethics, a Doctorate of Professional Studies in Bioethics, and Graduate Certificates in Clinical Ethics and Clinical Ethics Consultation. For more information on AMBI's online graduate programs, please visit our <a style="text-decoration: underline; color: #000099;" href="/Academic/bioethics/index.cfm">website</a>.</strong></p>
December 14, 2012

AJOB's December Issue is Here!

This month’s issue features:

What Purpose Does Religion Serve for Bioethics?

Connecting Global Health Justice and Governance

Published Articles (4)

American Journal of Bioethics: Volume 12 Issue 12 - Dec 2012

The Morality of Saved Lives Rajaie Batniji & Paul H. Wise

American Journal of Bioethics: Volume 12 Issue 12 - Dec 2012

Global Health Justice and Governance Jennifer Prah Ruger

American Journal of Bioethics: Volume 11 Issue 5 - May 2011

Beyond the IRB: Local Service Versus Global Oversight

American Journal of Bioethics: Volume 10 Issue 11 - Nov 2010

Review of Brad Spellberg, Rising Plague: The Global Threat from Deadly Bacteria and Our Dwindling Arsenal to Fight Them